Canopy Growth Corporation, a “world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives”, has launched Spectrum Reserve, a new premium medical cannabis brand in Canada.
Designed to meet the evolving needs of medical cannabis patients, Spectrum Reserve represents the peak of cannabis cultivation – featuring flower selected for size, potency, and terpene levels through rigorous in-house standards during cultivation and post-harvest.
Under this new program, Spectrum Reserve is expected to introduce new strains on a regular basis based on patient needs, preferences, and feedback. The strains which generate the most positive and consistent customer feedback will remain in market, while others will be phased out to make way for new genetics through a process of constant enhancement. This approach will help Spectrum Therapeutics consistently deliver new, premium quality strains to the medical cannabis market in Canada.
Continue reading